Showing results for:

Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides

In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL event on...

Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe...

Agreement Adds to Shionogi’s Growing Pipeline in Rare Disease MZE001 has the Potential to be the First Oral Therapy for Pompe Disease OSAKA, Japan & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao...

UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024

New and Recurrent Patients Treated with UGN-102 Achieved Similar Durability of Response Rates (DOR) at 12 months PRINCETON, N.J--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers,...

“It is one of the most incredible success stories” – Mallon on Guyana’s oil development 

The story of Guyana being just a tiny South American country to one of the most prolific oil producers in the world is remarkable, according to ExxonMobil Upstream President, Liam Mallon.  During his CERAWeek 2024 presentation, Mallon said, “It is...

SBM Offshore’s footprint in Guyana growing larger; 51 new vendors added in 2023

Fifty-one Guyanese companies were added to SBM Offshore Guyana’s vendor database in 2023, according to Garri Fraser, the company’s Local Content Officer.  Fraser gave insight on SBM Offshore’s local content strides, during the company’s 'Let’s Talk Local Content’ Seminar, held...

Almirall Licenses an Anti-IL-21 Monoclonal Antibody From Novo Nordisk to Develop It as a First-in-Class Agent in Dermatology

Almirall obtains exclusive global rights to develop and commercialize NN-8828 for use in several fields, including immune inflammatory dermatological diseases NN-8828 is an IL-21 blocker which inhibits the pathophysiological functions induced by this cytokine in several immune-modulated diseases  BARCELONA, Spain--(BUSINESS WIRE)--Almirall...

ExxonMobil’s Liza projects cop excellence award

ExxonMobil's Liza projects have been honored with the International Petroleum Technology Conference (IPTC) Excellence in Project Integration Award, recognizing outstanding achievements in executing oil and gas projects.  The award, presented during the 2024 IPTC in Dhahran, Nepal, highlighted the company's...

Liza field downtime to only last weeks, will not affect Exxon’s production targets  

ExxonMobil will be taking the Liza field offline to hook up the pipeline for Guyana’s Gas-to-Energy (GtE) project in the latter half of the year, but this is only expected to last weeks.  “I would say it's going to be...

Another Exxon-led project may connect to Gas-to-Energy pipeline alongside Liza

Guyana’s Natural Resources Minister, Vickram Bharrat, has confirmed to OilNOW that studies are underway to determine which of ExxonMobil’s Stabroek Block projects can utilize the additional capacity of the Gas-to-Energy pipeline, following start-up in 2025. Mr. Bharrat said, “The Liza...

Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional...

– Newly published data highlights additional efficacy endpoints from trial – – Linaclotide is the first and only FDA-approved prescription therapy for children and adolescents aged 6-17 years with functional constipation –BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare...

Latest News

The rise of Expro’s first Guyanese Field Service Supervisor, Norman Chapman 

When Norman Chapman joined Expro Guyana in 2018, then known as Frank’s International, he was one of just five...